 | • レポートコード：QFJ1-5456 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：新技術 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、遺伝子編集技術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（相同組換え、メガヌクレアーゼ）、用途別市場規模（農業、医療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・遺伝子編集技術の市場動向 ・企業の競争状況、市場シェア ・遺伝子編集技術の種類別市場規模と予測2016-2027（相同組換え、メガヌクレアーゼ） ・遺伝子編集技術の用途別市場規模と予測2016-2027（農業、医療、その他） ・遺伝子編集技術の北米市場規模2016-2027（アメリカ、カナダ） ・遺伝子編集技術の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・遺伝子編集技術のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・遺伝子編集技術の中南米市場規模2016-2027（メキシコ、ブラジル） ・遺伝子編集技術の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific、SIGMA ALDRICH、Dharmacon、Cellectics、CRISPR Therapeutics、AstraZeneca、Bio Rad、Allele Biotech、Recombinetics、Lonza、GE Healthcare、Editas Medicine、Agilent Technologies、QIAGEN NV） ・結論 |
Gene editing is a new and accurate genetic engineering technology that can modify specific target genes in the genome of an organism.
Gene editing technology refers to the ability for humans to “edit” targeted genes to achieve modifications to specific DNA fragments.
Gene editing relies on genetically engineered nucleases, also known as “molecular scissors,” to produce site-specific double-strand breaks (DSBs) at specific locations in the genome, inducing organisms to connect via non-homologous end junctions (NHEJ) or homologous Source Recombination (HR) to repair DSB because this repair process is error-prone, resulting in targeted mutations
In 2021, the global Gene Editing Technology market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Gene Editing Technology status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Gene Editing Technology development in North America, Europe, Japan, China, Southeast Asia, India, etc.
Global Gene Editing Technology Scope and Market Size
Gene Editing Technology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Editing Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Homologous Recombination
Meganuclease
Segment by Application
Agriculture
Medical
Other
By Region
North America
Europe
Japan
China
Southeast Asia
India
By Company
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
GE Healthcare
Editas Medicine
Agilent Technologies
QIAGEN NV
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Editing Technology Market Size Growth Rate by Type (2021-2027)
1.2.2 Homologous Recombination
1.2.3 Meganuclease
1.3 Market by Application
1.3.1 Global Gene Editing Technology Market Share by Application (2021-2027)
1.3.2 Agriculture
1.3.3 Medical
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Gene Editing Technology Market Size
2.2 Gene Editing Technology Market Size by Regions
2.2.1 Gene Editing Technology Growth Rate by Regions (2021-2027)
2.2.2 Gene Editing Technology Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Gene Editing Technology Revenue by Players (2020-2021)
3.2 Gene Editing Technology Key Players Headquaters and Area Served
3.3 Key Players Gene Editing Technology Product/Solution/Service
3.4 Date of Enter into Gene Editing Technology Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global Gene Editing Technology Market Size by Type (2021-2027)
4.2 Global Gene Editing Technology Market Size by Application (2021-2027)
5 North America
5.1 North America Gene Editing Technology Market Forecast (2021-2027)
5.2 Gene Editing Technology Key Players in North America
5.3 North America Gene Editing Technology Market Size by Type
5.4 North America Gene Editing Technology Market Size by Application
6.4.4 Canada
6 Europe
6.1 Europe Gene Editing Technology Market Forecast (2021-2027)
6.2 Gene Editing Technology Key Players in Europe
6.3 Europe Gene Editing Technology Market Size by Type
6.4 Europe Gene Editing Technology Market Size by Application
7 Japan
7.1 Japan Gene Editing Technology Market Forecast (2021-2027)
7.2 Gene Editing Technology Key Players in Europe
7.3 Japan Gene Editing Technology Market Size by Type
7.4 Japan Gene Editing Technology Market Size by Application
8 Rest of World
8.1 China
8.1.1 China Gene Editing Technology Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Gene Editing Technology Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Gene Editing Technology Market Analysis
8.3.2 Key Players in India
9 International Player Profiles
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Company Details
9.1.2 Thermo Fisher Scientific Description and Business Overview
9.1.3 Thermo Fisher Scientific Gene Editing Technology Introduction
9.1.4 Thermo Fisher Scientific Revenue in Gene Editing Technology Business (2020-2021)
9.1.5 Thermo Fisher Scientific Recent Development
9.2 SIGMA ALDRICH
9.2.1 SIGMA ALDRICH Company Details
9.2.2 SIGMA ALDRICH Description and Business Overview
9.2.3 SIGMA ALDRICH Gene Editing Technology Introduction
9.2.4 SIGMA ALDRICH Revenue in Gene Editing Technology Business (2020-2021)
9.2.5 SIGMA ALDRICH Recent Development
9.3 Dharmacon
9.3.1 Dharmacon Company Details
9.3.2 Dharmacon Description and Business Overview
9.3.3 Dharmacon Gene Editing Technology Introduction
9.3.4 Dharmacon Revenue in Gene Editing Technology Business (2020-2021)
9.3.5 Dharmacon Recent Development
9.4 Cellectics
9.4.1 Cellectics Company Details
9.4.2 Cellectics Description and Business Overview
9.4.3 Cellectics Gene Editing Technology Introduction
9.4.4 Cellectics Revenue in Gene Editing Technology Business (2020-2021)
9.4.5 Cellectics Recent Development
9.5 CRISPR Therapeutics
9.5.1 CRISPR Therapeutics Company Details
9.5.2 CRISPR Therapeutics Description and Business Overview
9.5.3 CRISPR Therapeutics Gene Editing Technology Introduction
9.5.4 CRISPR Therapeutics Revenue in Gene Editing Technology Business (2020-2021)
9.5.5 CRISPR Therapeutics Recent Development
9.6 AstraZeneca
9.6.1 AstraZeneca Company Details
9.6.2 AstraZeneca Description and Business Overview
9.6.3 AstraZeneca Gene Editing Technology Introduction
9.6.4 AstraZeneca Revenue in Gene Editing Technology Business (2020-2021)
9.6.5 AstraZeneca Recent Development
9.7 Bio Rad
9.7.1 Bio Rad Company Details
9.7.2 Bio Rad Description and Business Overview
9.7.3 Bio Rad Gene Editing Technology Introduction
9.7.4 Bio Rad Revenue in Gene Editing Technology Business (2020-2021)
9.7.5 Bio Rad Recent Development
9.8 Allele Biotech
9.8.1 Allele Biotech Company Details
9.8.2 Allele Biotech Description and Business Overview
9.8.3 Allele Biotech Gene Editing Technology Introduction
9.8.4 Allele Biotech Revenue in Gene Editing Technology Business (2020-2021)
9.8.5 Allele Biotech Recent Development
9.9 Recombinetics
9.9.1 Recombinetics Company Details
9.9.2 Recombinetics Description and Business Overview
9.9.3 Recombinetics Gene Editing Technology Introduction
9.9.4 Recombinetics Revenue in Gene Editing Technology Business (2020-2021)
9.9.5 Recombinetics Recent Development
9.10 Lonza
9.10.1 Lonza Company Details
9.10.2 Lonza Description and Business Overview
9.10.3 Lonza Gene Editing Technology Introduction
9.10.4 Lonza Revenue in Gene Editing Technology Business (2020-2021)
9.10.5 Lonza Recent Development
9.11 GE Healthcare
9.11.1 GE Healthcare Company Details
9.11.2 GE Healthcare Description and Business Overview
9.11.3 GE Healthcare Gene Editing Technology Introduction
9.11.4 GE Healthcare Revenue in Gene Editing Technology Business (2020-2021)
9.11.5 GE Healthcare Recent Development
9.12 Editas Medicine
9.12.1 Editas Medicine Company Details
9.12.2 Editas Medicine Description and Business Overview
9.12.3 Editas Medicine Gene Editing Technology Introduction
9.12.4 Editas Medicine Revenue in Gene Editing Technology Business (2020-2021)
9.12.5 Editas Medicine Recent Development
9.13 Agilent Technologies
9.13.1 Agilent Technologies Company Details
9.13.2 Agilent Technologies Description and Business Overview
9.13.3 Agilent Technologies Gene Editing Technology Introduction
9.13.4 Agilent Technologies Revenue in Gene Editing Technology Business (2020-2021)
9.13.5 Agilent Technologies Recent Development
9.14 QIAGEN NV
9.14.1 QIAGEN NV Company Details
9.14.2 QIAGEN NV Description and Business Overview
9.14.3 QIAGEN NV Gene Editing Technology Introduction
9.14.4 QIAGEN NV Revenue in Gene Editing Technology Business (2020-2021)
9.14.5 QIAGEN NV Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
Table 1. Global Gene Editing Technology Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Homologous Recombination
Table 3. Key Players of Meganuclease
Table 4. Global Gene Editing Technology Market Size Growth by Application (2021-2027) (US$ Million)
Table 5. Global Gene Editing Technology Market Size by Regions (2021-2027) (US$ Million)
Table 6. Global Gene Editing Technology Market Share by Regions (2021-2027)
Table 7. Market Top Trends
Table 8. Market Use Cases
Table 9. Global Gene Editing Technology Revenue by Players (2020-2021) (US$ Million)
Table 10. Global Gene Editing Technology Market Share by Players (2020-2021)
Table 11. Key Players Headquarters and Area Served
Table 12. Key Players Gene Editing Technology Product Solution and Service
Table 13. Date of Enter into Gene Editing Technology Market
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Global Gene Editing Technology Market Size by Type (2021-2027) (US$ Million)
Table 16. Global Gene Editing Technology Market Size Share by Type (2021-2027)
Table 17. Global Gene Editing Technology Market Size by Application (2021-2027) (US$ Million)
Table 18. Global Gene Editing Technology Market Size Share by Application (2021-2027)
Table 19. North America Key Players Gene Editing Technology Revenue (2020-2021) (US$ Million)
Table 20. North America Key Players Gene Editing Technology Market Share (2020-2021)
Table 21. North America Gene Editing Technology Market Size by Type (2021-2027) (US$ Million)
Table 22. North America Gene Editing Technology Market Share by Type (2021-2027)
Table 23. North America Gene Editing Technology Market Size by Application (2021-2027) (US$ Million)
Table 24. North America Gene Editing Technology Market Share by Application (2021-2027)
Table 25. Europe Key Players Gene Editing Technology Revenue (2020-2021) (US$ Million)
Table 26. Europe Key Players Gene Editing Technology Market Share (2020-2021)
Table 27. Europe Gene Editing Technology Market Size by Type (2021-2027) (US$ Million)
Table 28. Europe Gene Editing Technology Market Share by Type (2021-2027)
Table 29. Europe Gene Editing Technology Market Size by Application (2021-2027) (US$ Million)
Table 30. Europe Gene Editing Technology Market Share by Application (2021-2027)
Table 31. Japan Key Players Gene Editing Technology Revenue (2020-2021) (US$ Million)
Table 32. Japan Key Players Gene Editing Technology Market Share (2020-2021)
Table 33. Japan Gene Editing Technology Market Size by Type (2021-2027) (US$ Million)
Table 34. Japan Gene Editing Technology Market Share by Type (2021-2027)
Table 35. Japan Gene Editing Technology Market Size by Application (2021-2027) (US$ Million)
Table 36. Japan Gene Editing Technology Market Share by Application (2021-2027)
Table 37. Key Players in China
Table 38. Key Players in Southeast Asia
Table 39. Key Players in India
Table 40. Thermo Fisher Scientific Company Details
Table 41. Thermo Fisher Scientific Description and Business Overview
Table 42. Thermo Fisher Scientific Gene Editing Technology Product
Table 43. Thermo Fisher Scientific Revenue in Gene Editing Technology Business 2020 and 2021
Table 44. Thermo Fisher Scientific Recent Development
Table 45. SIGMA ALDRICH Company Details
Table 46. SIGMA ALDRICH Description and Business Overview
Table 47. SIGMA ALDRICH Gene Editing Technology Product
Table 48. SIGMA ALDRICH Revenue in Gene Editing Technology Business 2020 and 2021
Table 49. SIGMA ALDRICH Recent Development
Table 50. Dharmacon Company Details
Table 51. Dharmacon Description and Business Overview
Table 52. Dharmacon Gene Editing Technology Product
Table 53. Dharmacon Revenue in Gene Editing Technology Business 2020 and 2021
Table 54. Dharmacon Recent Development
Table 55. Cellectics Company Details
Table 56. Cellectics Description and Business Overview
Table 57. Cellectics Gene Editing Technology Product
Table 58. Cellectics Revenue in Gene Editing Technology Business 2020 and 2021
Table 59. Cellectics Recent Development
Table 60. CRISPR Therapeutics Company Details
Table 61. CRISPR Therapeutics Description and Business Overview
Table 62. CRISPR Therapeutics Gene Editing Technology Product
Table 63. CRISPR Therapeutics Revenue in Gene Editing Technology Business 2020 and 2021
Table 64. CRISPR Therapeutics Recent Development
Table 65. AstraZeneca Company Details
Table 66. AstraZeneca Description and Business Overview
Table 67. AstraZeneca Gene Editing Technology Product
Table 68. AstraZeneca Revenue in Gene Editing Technology Business 2020 and 2021
Table 69. AstraZeneca Recent Development
Table 70. Bio Rad Company Details
Table 71. Bio Rad Description and Business Overview
Table 72. Bio Rad Gene Editing Technology Product
Table 73. Bio Rad Revenue in Gene Editing Technology Business 2020 and 2021
Table 74. Bio Rad Recent Development
Table 75. Allele Biotech Company Details
Table 76. Allele Biotech Description and Business Overview
Table 77. Allele Biotech Gene Editing Technology Product
Table 78. Allele Biotech Revenue in Gene Editing Technology Business 2020 and 2021
Table 79. Allele Biotech Recent Development
Table 80. Recombinetics Company Details
Table 81. Recombinetics Description and Business Overview
Table 82. Recombinetics Gene Editing Technology Product
Table 83. Recombinetics Revenue in Gene Editing Technology Business 2020 and 2021
Table 84. Recombinetics Recent Development
Table 85. Lonza Company Details
Table 86. Lonza Description and Business Overview
Table 87. Lonza Gene Editing Technology Product
Table 88. Lonza Revenue in Gene Editing Technology Business 2020 and 2021
Table 89. Lonza Recent Development
Table 90. GE Healthcare Company Details
Table 91. GE Healthcare Description and Business Overview
Table 92. GE Healthcare Gene Editing Technology Product
Table 93. GE Healthcare Revenue in Gene Editing Technology Business 2020 and 2021
Table 94. GE Healthcare Recent Development
Table 95. Editas Medicine Company Details
Table 96. Editas Medicine Description and Business Overview
Table 97. Editas Medicine Gene Editing Technology Product
Table 98. Editas Medicine Revenue in Gene Editing Technology Business 2020 and 2021
Table 99. Editas Medicine Recent Development
Table 100. Agilent Technologies Company Details
Table 101. Agilent Technologies Description and Business Overview
Table 102. Agilent Technologies Gene Editing Technology Product
Table 103. Agilent Technologies Revenue in Gene Editing Technology Business 2020 and 2021
Table 104. Agilent Technologies Recent Development
Table 105. QIAGEN NV Company Details
Table 106. QIAGEN NV Description and Business Overview
Table 107. QIAGEN NV Gene Editing Technology Product
Table 108. QIAGEN NV Revenue in Gene Editing Technology Business 2020 and 2021
Table 109. QIAGEN NV Recent Development
Table 110. Gene Editing Technology Market Trends
Table 111. Gene Editing Technology Market Drivers
Table 112. Gene Editing Technology Market Challenges
Table 113. Gene Editing Technology Market Restraints
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Editing Technology Market Share by Type in 2021 & 2027
Figure 2. Homologous Recombination Features
Figure 3. Meganuclease Features
Figure 4. Global Gene Editing Technology Market Share by Application in 2021 & 2027
Figure 5. Agriculture Case Studies
Figure 6. Medical Case Studies
Figure 7. Other Case Studies
Figure 8. Gene Editing Technology Report Years Considered
Figure 9. Global Gene Editing Technology Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 10. Global Gene Editing Technology Market Share by Regions (2020-2027)
Figure 11. Global Gene Editing Technology Market Share by Players in 2021
Figure 12. Global Gene Editing Technology Market Size Market Share by Type (2021-2027)
Figure 13. Global Gene Editing Technology Market Size Market Share by Application (2021-2027)
Figure 14. Global Gene Editing Technology Revenue Market Share by Application in 2021
Figure 15. North America Gene Editing Technology Market Size 2021-2027 (US$ Million)
Figure 16. Europe Gene Editing Technology Market Size 2021-2027 (US$ Million)
Figure 17. Japan Gene Editing Technology Market Size 2021-2027 (US$ Million)
Figure 18. Gene Editing Technology Market Size in China (2021-2027) (US$ Million)
Figure 19. Gene Editing Technology Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 20. Gene Editing Technology Market Size in India (2021-2027) (US$ Million)
Figure 21. Bottom-up and Top-down Approaches for This Report
Figure 22. Data Triangulation
Figure 23. Key Executives Interviewed
世界の遺伝子編集ツール市場規模・現状・予測（2021年-2027年） Gene editing (or genome editing) is the insertion, deletion or replacement of DNA at a specific site in the genome of an organism or cell. It is usually achieved in the lab using engineered nucleases also known as molecular scissors. Market Analysis and Insights: Global Gene Editing Tools Market The…- 世界のCRISPRゲノム編集市場規模・現状・予測（2021年-2027年） CRISPR Genome editing is a group of technologies that give scientists the ability to change CRISPR. Market Analysis and Insights: Global CRISPR Genome Editing Market The global CRISPR Genome Editing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of X…
- 世界の感受性遺伝子検出市場規模・現状・予測（2021年-2027年） It is a method of deciphering the genetic code carried by the human body through molecular biology methods, thereby predicting the probability of an individual suffering from certain diseases in the future Market Analysis and Insights: Global Susceptibility Gene Detection Market The global Susceptib…
- 世界のタバコ代謝遺伝子検査市場規模・現状・予測（2021年-2027年） A detection method for cigarette metabolism Market Analysis and Insights: Global Cigarette Metabolism Gene Testing Market The global Cigarette Metabolism Gene Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…
- 世界の遺伝性難聴遺伝子検出市場規模・現状・予測（2021年-2027年） A method for detecting and diagnosing hereditary deafness Market Analysis and Insights: Global Hereditary Deafness Gene Detection Market The global Hereditary Deafness Gene Detection market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2…